semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 2·4 mg once
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
![semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 24 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 24 mg once](https://figures.semanticscholar.org/898978c1b0543b943d605e293f5296fb7568cee7/6-Figure2-1.png)
![semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 24 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 24 mg once](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-025-03944-9/MediaObjects/41591_2025_3944_Fig1_HTML.png)
![semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 24 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 24 mg once](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/AD_4nXecYXk7BfwC6adHH808V596nosg2pYs4yDUs6TBM_JMmx7_pGkjqpOwyHWy2Rj2TdJt-SPUxEipYqiO5CftWX-CaAm_fXRTU6dpEuJkuUscaLenZ1xGLWDdf_XVsOIjaZt08BpA4A.png)
![semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 24 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 24 mg once](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de6/7318657/aa9e3caa063c/OBY-28-1050-g002.jpg)
![semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 24 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 PDF] Semaglutide 24 mg once](https://cdn.sanity.io/images/0vv8moc6/ajmc/6c07a872b2e127bdab1fe9698d7663a05995126a-2187x1121.jpg/AJMC_AJP1151_Obesity_Article04_Figure.jpg?w=2187&max-h=1121&fit=crop&auto=format)
























